INVO Fertility, Inc. (IVF) vs NEXGEL, Inc. (NXGL)

A side-by-side comparison of INVO Fertility, Inc. and NEXGEL, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IVF vs NXGL

growth of $100 · dividends reinvested · last 5y
IVF -100.0% (-90.6%/yr)NXGL -95.2% (-45.5%/yr)NXGL compounded faster over this window
Log scale — wide-divergence pair
00001101001kStart $10020222023202420252026$0$5
IVF NXGL

IVF vs NXGL: by the numbers

  • •NXGL is the larger company ($1M vs $1M market cap).
  • •Both run net losses; NXGL's is the smaller (-51.26% vs -70.18% net margin).
  • •NXGL grew revenue faster over the past five years (63.69% vs 39.51% CAGR).

Metrics side by side

Valuation

MetricIVFNXGL
P/S ratio0.190.12
P/B ratio0.090.29

Profitability

MetricIVFNXGL
Gross margin33.34%35.07%
Operating margin-78.72%-29.35%
Net margin-70.18%-51.26%
ROE-32.05%-124.97%
ROIC-28.43%-41.80%

Growth (annualized)

MetricIVFNXGL
Revenue CAGR (5Y)39.51%63.69%
Total return CAGR (5Y)-90.41%N/A

Frequently asked

Which has grown faster, IVF or NXGL?
Over the past five years, NXGL grew revenue faster — IVF at a 39.51% CAGR versus NXGL at 63.69%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.